| Pancreatic cancer JD Mizrahi, R Surana, JW Valle, RT Shroff The Lancet 395 (10242), 2008-2020, 2020 | 1805 | 2020 |
| Pancreas cancer-associated pain management AL Coveler, J Mizrahi, B Eastman, SJ Apisarnthanarax, S Dalal, ... The oncologist 26 (6), e971-e982, 2021 | 45 | 2021 |
| Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients C Mohindroo, M Hasanov, JE Rogers, W Dong, LR Prakash, S Baydogan, ... Cancer medicine 10 (15), 5041-5050, 2021 | 40 | 2021 |
| Modified FOLFIRINOX in pancreatic cancer patients age 75 or older JD Mizrahi, JE Rogers, KR Hess, RA Wolff, GR Varadhachary, MM Javle, ... Pancreatology 20 (3), 501-504, 2020 | 36 | 2020 |
| New treatment options for advanced biliary tract cancer JD Mizrahi, RT Shroff Current Treatment Options in Oncology 21 (8), 63, 2020 | 29 | 2020 |
| Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancers JD Mizrahi, V Gunchick, K Mody, L Xiao, P Surapaneni, RT Shroff, ... World Journal of Gastrointestinal Oncology 12 (1), 83, 2020 | 17 | 2020 |
| Immunotherapy in gastrointestinal malignancies J Mizrahi, S Pant Immunotherapy, 93-106, 2020 | 9 | 2020 |
| A retrospective analysis of antibiotics usage and effect on overall survival and progressive free survival in patients with metastatic pancreatic cancer. C Mohindroo, JE Rogers, M Hasanov, J Mizrahi, MJ Overman, ... Journal of Clinical Oncology 37 (15_suppl), e15781-e15781, 2019 | 7 | 2019 |
| Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injury JD Mizrahi, MJ Overman Oncotarget 9 (79), 34857, 2018 | 7 | 2018 |
| Modified gemcitabine plus nab‐paclitaxel regimen in advanced pancreatic ductal adenocarcinoma JE Rogers, JD Mizrahi, L Xiao, C Mohindroo, RT Shroff, R Wolff, ... Cancer medicine 9 (15), 5406-5415, 2020 | 6 | 2020 |
| Dose-modified gemcitabine plus nab-paclitaxel front-line in advanced pancreatic ductal adenocarcinoma with baseline hyperbilirubinemia JE Rogers, JD Mizrahi, RT Shroff, DA Nelson, J Tu, MM Javle, RA Wolff, ... Journal of Gastrointestinal Oncology 11 (1), 55, 2020 | 6 | 2020 |
| FOLFIRI in advanced biliary tract cancers. J Mizrahi, V Gunchick, K Mody, L Xiao, PK Surapaneni, RT Shroff, V Sahai Journal of Clinical Oncology 37 (4_suppl), 451-451, 2019 | 5 | 2019 |
| FOLFIRINOX in pancreatic cancer patients age 75 years or older. J Mizrahi, J Rogers, KR Hess, RA Wolff, GR Varadhachary, RT Shroff, ... Journal of Clinical Oncology 37 (4_suppl), 362-362, 2019 | 5 | 2019 |
| A phase II study of ramucirumab for advanced, pre-treated biliary cancers. J Mizrahi, MM Javle, L Xiao, GR Varadhachary, KPS Raghav, RA Wolff, ... Journal of Clinical Oncology 36 (15_suppl), 4081-4081, 2018 | 5 | 2018 |
| Abstract B36: maintenance chemotherapy after chemoradiation in patients with locally advanced pancreatic cancer JD Mizrahi, S Moningi, GM Nogueras-Gonzalez, RA Wolff, MM Javle, ... Cancer Research 79 (24_Supplement), B36-B36, 2019 | 1 | 2019 |
| Clinical trials and novel/emerging treatment JD Mizrahi, R Abdel-Wahab, M Javle Intrahepatic Cholangiocarcinoma: Diagnosis and Management, 183-208, 2019 | 1 | 2019 |
| Care delivery and patient self-management for people with primary liver cancer receiving 4R care sequence plans. G Therapondos, CB Weldon, L Du, J Mizrahi, C Palmer, A Medina, ... Journal of Clinical Oncology 42 (3_suppl), 465-465, 2024 | | 2024 |
| Gaps in care planning and delivery for patients with liver cancer: Baseline assessment for implementation of 4R Oncology model. G Therapondos, JR Trosman, L Du, J Mizrahi, T Sandow, A Cohen, ... JCO Oncology Practice 19 (11_suppl), 381-381, 2023 | | 2023 |
| Pulmonary Tumor Thrombotic Microangiopathy Caused by Esophageal Adenocarcinoma: A Case Report JO Peeples, J King, V Chung, L Maley, J Mizrahi, JD Mizrahi Cureus 15 (8), 2023 | | 2023 |
| Management of Locally Advanced/Metastatic Disease: Medical Oncology JD Mizrahi, RA Wolff Pancreatic Cancer: A Multidisciplinary Approach, 97-106, 2022 | | 2022 |
